Yangtze River Pharmaceutical Industry: high quality development acceleration

To strengthen the national medicine brand and build a new benchmark for the modernization of traditional Chinese medicine Yangtze River Pharmaceutical Industry: to achieve high-quality development acceleration, "2019 China Pharmaceutical entrepreneur scientist investor conference and the 70th anniversary of the founding of new China pharmaceutical industry development achievement exhibition" was recently held in Beijing Yangtze River Pharmaceutical industry won the honor of "the backbone enterprise of the 70th anniversary of the founding of new China pharmaceutical industry" On November 21 last year, the "2019 China Financial Summit winter forum and global new business conference" was held in Beijing, and the Yangtze River Pharmaceutical industry was awarded the "industry leading brand of 2019" "We always adhere to the main business, focus on quality, and strive to push national pharmaceutical brands to the world stage." Xu Jingren, chairman of Yangzijiang Pharmaceutical Group, said that since the 18th National Congress of the Communist Party of China, Yangzijiang people have actively implemented the new development concept, accelerated the transformation to the great health of traditional Chinese medicine, and paid more attention to the product efficacy The road of high quality benefiting the people has become wider and wider, and ran out of the "acceleration" of high-quality development of traditional Chinese medicine In August 2019, a "drug selection" problem that has puzzled Yangzijiang pharmaceutical industry for many years was solved by Wang Wei, deputy director of solid preparation workshop 3 of the group It turns out that in the production of Roxithromycin Capsules, because the powder is relatively thin, there will be appearance defects when the machine is filled, so it is always necessary to remove them by manual "drug selection" Wang Wei led the technical personnel to carry out the research Through the continuous optimization and commissioning of the filling equipment of Roxithromycin Capsules, the product rate of appearance defects was reduced to zero, and the production workshop simplified 14 drug picking employees There are many "Yangtze River craftsmen" like Wang Wei who are struggling in the front line Li Jin and Gao Xiaofei from the Yangtze River Pharmaceutical industry won the first and third place respectively in the "Yangtze River Cup" Jiangsu pharmaceutical workers' skill competition held in late November last year and the fifth Jiangsu pharmaceutical industry specific professional skill competition Paying attention to the whole process of quality, we should control the people's awe of quality from the heart, and not allow any carelessness and flaws The quality spirit of "no difficulty can beat us, only quality" and the quality culture of "pharmaceutical for parents, pharmaceutical for relatives" are deeply integrated into the blood of every Yangtze River people and the gene of high quality and benefiting the people of the Yangtze River QC (quality control) group is the cradle of "Yangtze River craftsman" More than 120 QC groups have been active in all lines of the group all the year round They have carried out more than 1000 QC projects of various types, and have overcome many technical problems in the industry such as "new method for determination of trace heavy metal elements in traditional Chinese medicine" Up to now, Yangzijiang pharmaceutical has won the first prize of "15 consecutive titles" in the total number of QC achievement Publishing Awards in the national pharmaceutical industry In recent five years, it has also participated in the international QC achievement publishing competition on behalf of Chinese enterprises, and won 20 gold awards in total, making a great show on the international quality competition stage Quality is the foundation of brand In 2018, Yangzijiang Pharmaceutical Co., Ltd stood out from 225 manufacturing enterprises and won the nomination award of China Quality Award In the first half of 2019, with 980 points of brand strength and 42.869 billion yuan of brand value, the enterprise won the "double first" brand strength and brand value of China's medical and health sector In August 2019, Yangzijiang Pharmaceutical Co., Ltd once again won the top 100 list of China's pharmaceutical industry and won the "five consecutive titles" Inheriting and innovating, building a new benchmark of modernization of traditional Chinese medicine in the oral liquid production workshop of longfengtang traditional Chinese Medicine Co., Ltd., a modern production line runs at high speed, and a box of finished products is continuously delivered to the three-dimensional elevated warehouse along with the conveyor belt Song Min, the person in charge of the base, told the author that longfengtang integrated logistics of traditional Chinese medicine took the lead in realizing automatic transmission, and the extraction workshop took the lead in realizing robot feeding in the country Among them, the production of Lanqin oral liquid is automated, and all production data are automatically collected and recorded, which greatly ensures the consistency of product quality The system also collects and analyzes data, and regularly uses the data analysis results to feed back the production process, creating a new mode for the quality management of traditional Chinese medicine production In the context of the implementation of the "healthy China strategy", the traditional Chinese medicine industry ushered in a broader development space "To promote the modernization of traditional Chinese medicine industry is not only the sacred mission entrusted to us by history, but also the urgent need of enterprise transformation and development." Xu Jingren said that in recent years, the group has accelerated the construction of longfengtang traditional Chinese medicine industry project, which has set a number of first in the construction of traditional Chinese medicine intelligent factory The application of information, big data and intelligence has led longfengtang into a new era of innovation and development of traditional Chinese medicine industry, striving to become a new benchmark for the modernization of traditional Chinese medicine industry Longfengtang has established 34 standardized planting bases for traditional Chinese medicine in qidadaodi medicinal material production area, covering an area of 6600 hectares They implement the whole process quality management from basic source research, field management, pesticide and fertilizer supervision to harvesting, processing and transportation in accordance with the requirements of gap issued by the state At the same time, the whole process quality traceability system of longfengtang was established to manage the whole process of traditional Chinese medicine planting, production and circulation of decoction pieces and preparations, which basically realized that the source of traditional Chinese medicine products could be checked, the destination could be traced, the quality could be controlled and the responsibility could be investigated In addition, they also carried out fingerprint studies on some herbal medicines to maximize the overall characteristics of traditional Chinese medicine and provide scientific basis for the quality control of the whole process of traditional Chinese medicine In order to strengthen the research and development of new products of traditional Chinese medicine, the group's traditional Chinese Medicine Research Institute has a research team of more than 100 people, including more than 80% of those with master's degree or above, and 4 academicians as intellectual support With high-quality clinical research, we have successively promoted Suhuang Zhike capsule, Shuanghua Baihe tablet and other Yangtze River products to enter the national medical insurance drug catalog and national essential drug catalog Yangzijiang pharmaceutical also actively linked up with the national strategy, and the declared national high-tech industry standardization pilot project of Chinese medicine process intelligent manufacturing was selected into the "national high tech industry standardization pilot project" They have also undertaken the research work of 15 Monographs on Chinese herbal medicine European Pharmacopoeia, and independently researched varieties such as Hydrangea, Polygonum cuspidatum, Houttuynia cordata and zeylang have been included in European Pharmacopoeia, making pioneering contributions to the internationalization of Chinese herbal standards It is a new generation of pure traditional Chinese medicine stomach medicine developed by Yangzijiang people It has been listed as "recommended product to EU market" The enterprise later developed the Weisu effervescent tablet, but after the product was put into production, it was found that the effervescent tablet occasionally inflated For this reason, the product workshop set up a research team, and team members Li Min, Xu Youkun and others found out the reasons in many ways, and finally overcome the technical difficulties by taking measures such as optimizing granulation process, drying process and improving packaging methods Since then, this research group has also participated in the 44th international QC conference and won the gold medal Following the requirements of the national "medical treatment, medical insurance and medicine" three medical linkage reform, Yangzijiang pharmaceutical industry is committed to providing high-quality drugs and efficient health services, and striving to make patients in rural and urban communities can afford and buy drugs with good effects It is a revolution that affects the health of hundreds of millions of people to carry out the consistency evaluation of quality and efficacy of generic drugs Yangzijiang Pharmaceutical Co., Ltd has applied for 43 consistency evaluation projects, of which 20 varieties have passed the consistency evaluation and 12 varieties have been evaluated first in China These drugs have achieved the same efficacy as the original drugs, and can be replaced by imported drugs At the same time, more and more patients are benefiting from the traditional Chinese medicine products developed by Yangtze River people In 2015, the group's Ginkgo biloba extract and Ginkgo biloba leaves took the lead in passing the EU GMP certification Today, more than 10 varieties of traditional Chinese medicine, such as Weisu granules, Lanqin oral liquid, Huangqi essence, are exported to more than 10 countries and regions, including Russia, Singapore, Thailand, Indonesia, etc Yangtze River Pharmaceutical industry is not only a leader in pharmaceutical industry, but also a pioneer in "health poverty alleviation" The Group continues to promote the cause of "health poverty alleviation", and successively implements health poverty alleviation projects in Guizhou, Yunnan, Hainan, Shaanxi, Shanxi, Guangxi, Jiangxi and other provinces and regions Through "pairing" precision assistance of hospitals, experts go to the grass-roots level, special free clinics, donation of medical association study huts and medicine materials, assistance in building village clinics in poor areas and other forms, the group has invested over 100 million yuan in various poverty alleviation funds 。 Looking forward to the future, the Yangtze River people will make greater determination and efforts to push the high-quality development of traditional Chinese medicine industry into depth, and contribute to the wisdom of the Yangtze River for human health.